ArticleEuropean journal of medical research2024
Predicting the risk of pulmonary embolism in patients with tuberculosis using machine learning algorithms.
Article in European journal of medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Harnessing hybrid stacking ensemble learning for accurate pulmonary embolism diagnosis using tabular clinical data.Scientific reports · 2026Article
- Comorbidity of chronic obstructive pulmonary disease and pulmonary tuberculosis: a bibliometric analysis (2011-2025) with narrative review.Journal of thoracic disease · 2026Article
- D-Dimer: A Mediator of the Association Between Lymphocyte and Dissemination of Pulmonary Tuberculosis: A Retrospective Cohort Study.The clinical respiratory journal · 2026Article
- Analysis of High-Risk Factors for Tuberculosis Retreatment Based on Machine Learning and Latent Class Analysis.Infection and drug resistance · 2026Article
- Development and validation of a nomogram for predicting pulmonary embolism in patients with pulmonary tuberculosis.Journal of thoracic disease · 2025Article
- Research progress of artificial intelligence and machine learning in pulmonary embolism.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study aimed to develop predictive models with robust generalization capabilities for assessing the risk of pulmonary embolism in patients with tuberculosis using machine learning algorithms.
methodsData were collected from two centers and categorized into development and validation cohorts. Using the development cohort, candidate variables were selected via the Recursive Feature Elimination (RFE) method. Five machine learning algorithms, logistic regression (LR), random forest (RF), extreme gradient boosting (XGBoost), light gradient boosting machine (LightGBM), and support vector machine (SVM), were utilized to construct the predictive models. Model performance was evaluated through nested cross-validation and area under the curve (AUC) metrics, supplemented by interpretations using Shapley Additive explanations (SHAP) and line charts of AUC values. Models were subjected to external validation using an independent validation group, facilitating the early identification and management of pulmonary embolism risks in tuberculosis patients.
resultsData from 694 patients were used for model development, and 236 patients from the validation group met the enrollment criteria. The optimal subset of variables identified included D-dimer, smoking status, dyspnea, age, sex, diabetes, platelet count, cough, fibrinogen, hemoglobin, hemoptysis, hypertension, chronic obstructive pulmonary disease (COPD), and chest pain. The RF model outperformed others, achieving an AUC of 0.839 (95% CI 0.780-0.899) and maintaining the highest average performance in external fivefold cross-validation (AUC: 0.906 ± 0.041).
conclusionsThe RF model demonstrates high and consistent effectiveness in predicting pulmonary embolism risk in tuberculosis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.